|
|
|
|
|
|
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder
To explore the effectiveness of psilocybin-assisted therapy on reducing alcohol consumption in a double-blind, randomised, phase II clinical trial.
100 项与 Woke Pharmaceuticals Ltd. 相关的临床结果
0 项与 Woke Pharmaceuticals Ltd. 相关的专利(医药)
100 项与 Woke Pharmaceuticals Ltd. 相关的药物交易
100 项与 Woke Pharmaceuticals Ltd. 相关的转化医学